Albiflorin inhibits osteoclastogenesis and titanium particles-induced osteolysis via inhibition of ROS accumulation and the PI3K/AKT signaling pathway
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.113245 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Qiufei Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China; Department of Orthopedics, Changshu Hospital …. Hauptthemen laut MEDLINE: Titanium, Proto-Oncogene Proteins c-akt, Osteolysis, Reactive Oxygen Species. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Periprosthetic osteolysis (PPO), caused by wear particles, is a significant complication of total joint replacement, leading to prosthesis failure. Previous research has highlighted the crucial role of osteoclast-induced bone destruction in PPO progression. Albiflorin (AF), a monoterpene glycoside from Paeonia lactiflora, is a key active ingredient known for its antioxidant and anti-inflammatory properties. Although AF has shown promise in treating various conditions, its impact on osteoclasts and PPO remains unexplored. Our study revealed that AF could effectively inhibit osteoclast differentiation to reduce overactivated bone resorption and effectively inhibit the accumulation of reactive oxygen species (ROS) induced by wear particles. In vitro experiments also confirmed that AF could effectively inhibit the PI3K/AKT signaling pathway and inhibit inflammation to regulate osteoclast generation. Studies in animal models have also verified the antioxidant and anti-inflammatory properties of AF. In summary, the above studies indicate that AF inhibits osteoclastogenesis via inhibiting ROS accumulation and the PI3K/AKT signaling pathway, which may be a potential therapeutic method for PPO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China; Department of Orthopedics, Changshu Hospital Affiliated to Soochow University, First People's Hospital of Changshu…
- Department of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
- Department of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China; Department of Orthopedics, Hai'an People's Hospital, Zhongba Road 17, Hai'an, Jiangsu, China.
- Department of Dermatology and Venereology, Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China. Electronic address: bruceshi1227@163.com.
- Department of Orthopedics, Changshu Hospital Affiliated to Soochow University, First People's Hospital of Changshu City, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China; Department of Orthope…
- Department of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. Electronic address: xuyaozeng@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, Q., Tao, H., Wang, H., Chen, K., Zhu, P., Chen, W., Shi, F., Gu, Y., Xu, Y., & Geng, D. (2024). Albiflorin inhibits osteoclastogenesis and titanium particles-induced osteolysis via inhibition of ROS accumulation and the PI3K/AKT signaling pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113245
Vancouver
Wang Q, Tao H, Wang H, Chen K, Zhu P, Chen W, et al. Albiflorin inhibits osteoclastogenesis and titanium particles-induced osteolysis via inhibition of ROS accumulation and the PI3K/AKT signaling pathway. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113245
BibTeX
@article{Wang2024,
author = {Wang, Qiufei and Tao, Huaqiang and Wang, Heng and Chen, Kai and Zhu, Pengfei and Chen, Wenxiang and Shi, Feng and Gu, Ye and Xu, Yaozeng and Geng, Dechun},
title = {Albiflorin inhibits osteoclastogenesis and titanium particles-induced osteolysis via inhibition of ROS accumulation and the PI3K/AKT signaling pathway},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.113245}
}
EUVIMED